FDA fast-track approval creating acceleration — breakthrough therapy (BT) designation and expedited FDA pathways enabling accelerated drug development and approval for therapies addressing serious unmet medical needs through reduced regulatory burden and priority review, establishing fast-track pathways as essential drug development infrastructure supporting rapid therapeutic access for...